TNFRSF10A and neuroblastoma: Abhari et al. studied the cooperative activity of a panel of small-molecule IAP with monoclonal antibodies against TRAIL receptor 1 (Mapatumumab) or TRAIL-R2 (Lexatumumab) to induce apoptosis in neuroblastoma cells.